| 51 |
32624377 | Transdermal buprenorphine patch versus oral celecoxib for pain management after total knee arthroplasty: An open- label, randomized controlled trial. | 2020 Sep |
1 |
| 52 |
32658799 | Juvenile recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: Initial report. | 2020 Oct |
1 |
| 53 |
32705218 | Potentiation of TRAIL‑induced cell death by nonsteroidal anti‑inflammatory drug in human hepatocellular carcinoma cells through the ER stress‑dependent autophagy pathway. | 2020 Sep |
2 |
| 54 |
32741915 | Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents. | 2020 |
2 |
| 55 |
32801081 | Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives. | 2020 Sep |
2 |
| 56 |
32899627 | Design and Synthesis of a Novel NIR Celecoxib-Based Fluorescent Probe for Cyclooxygenase-2 Targeted Bioimaging in Tumor Cells. | 2020 Sep 4 |
1 |
| 57 |
32905529 | Estrogen receptor-β signaling induces cisplatin resistance in bladder cancer. | 2020 |
1 |
| 58 |
32966814 | AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication. | 2020 Dec |
1 |
| 59 |
32967672 | miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators. | 2020 Sep 23 |
2 |
| 60 |
33011534 | Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE2, TNF-α, IL-6 and histopathological study. | 2020 Nov |
2 |
| 61 |
33072916 | Down-regulation of COX-2 activity by 1α,25(OH)2D3 is VDR dependent in endothelial cells transformed by Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. | 2020 Oct |
1 |
| 62 |
33148606 | The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling. | 2020 Nov 12 |
1 |
| 63 |
33166844 | Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies. | 2020 Dec |
1 |
| 64 |
33194674 | Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. | 2020 |
1 |
| 65 |
30073924 | Celecoxib in Cancer Therapy and Prevention - Review. | 2019 |
1 |
| 66 |
30278282 | Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors. | 2019 Feb |
1 |
| 67 |
30391698 | New benzimidazothiazole derivatives as anti-inflammatory, antitumor active agents: Synthesis, in-vitro and in-vivo screening and molecular modeling studies. | 2019 Mar |
1 |
| 68 |
30398124 | Efficacy of Celecoxib Adjunct Treatment on Bipolar Disorder: Systematic Review and Meta-Analysis. | 2019 |
1 |
| 69 |
30508771 | Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: Dual cyclooxygenase/carbonic anhydrase inhibitory actions. | 2019 Mar |
1 |
| 70 |
30602073 | Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines. | 2019 Feb 5 |
1 |
| 71 |
30673592 | Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation. | 2019 Apr 28 |
1 |
| 72 |
30763886 | Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds. | 2019 May |
2 |
| 73 |
30807897 | Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies. | 2019 Apr |
1 |
| 74 |
30878890 | Novel aryl carboximidamide and 3-aryl-1,2,4-oxadiazole analogues of naproxen as dual selective COX-2/15-LOX inhibitors: Design, synthesis and docking studies. | 2019 Apr |
2 |
| 75 |
30929580 | Potentially inappropriate concomitant medicine use with the selective COX-2 inhibitor celecoxib: Analysis and comparison of spontaneous adverse event reports from Australia, Canada and the USA. | 2019 Mar |
1 |
| 76 |
31019986 | Effects of Perioperative Nonsteroidal Anti-inflammatory Drug Administration on Soft Tissue Healing: A Systematic Review of Clinical Outcomes After Sports Medicine Orthopaedic Surgery Procedures. | 2019 Apr |
1 |
| 77 |
31022559 | Parainfluenza virus infection enhances NSAIDs-induced inhibition of PGE2 generation and COX-2 expression in human airway epithelial cells. | 2019 Sep |
1 |
| 78 |
31048000 | Evaluation of selective and non-selective cyclooxygenase inhibitors on sulfur mustard-induced pro-inflammatory cytokine formation in normal human epidermal keratinocytes. | 2019 Sep 15 |
1 |
| 79 |
31075742 | Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold. | 2019 Jul |
1 |
| 80 |
31123968 | Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblasts of patients with rheumatoid arthritis. | 2019 Dec |
4 |
| 81 |
31139556 | Redox-Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin-Promoted Cancer Stemness, Metastasis, and Drug Resistance. | 2019 Apr 3 |
2 |
| 82 |
31212177 | Design, synthesis of celecoxib-tolmetin drug hybrids as selective and potent COX-2 inhibitors. | 2019 Sep |
1 |
| 83 |
31214060 | COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders. | 2019 |
1 |
| 84 |
31277138 | A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients: A preliminary, three-center, clinical trial study. | 2019 Jul |
1 |
| 85 |
31336734 | Enhanced Oral Bioavailability of Celecoxib Nanocrystalline Solid Dispersion based on Wet Media Milling Technique: Formulation, Optimization and In Vitro/In Vivo Evaluation. | 2019 Jul 11 |
2 |
| 86 |
31339385 | Celecoxib for the treatment of musculoskeletal arthritis. | 2019 Oct |
1 |
| 87 |
31611604 | Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells. | 2019 Oct 14 |
1 |
| 88 |
31623608 | pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer. | 2019 Oct 17 |
2 |
| 89 |
29351170 | Risk of preterm birth following late pregnancy exposure to NSAIDs or COX-2 inhibitors. | 2018 May |
1 |
| 90 |
29400411 | Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors. | 2018 Apr |
1 |
| 91 |
29487225 | Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. | 2018 May |
1 |
| 92 |
29515134 | Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux. | 2018 Mar 7 |
2 |
| 93 |
29550530 | Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies. | 2018 Aug |
1 |
| 94 |
29550533 | Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study. | 2018 Aug |
1 |
| 95 |
29593389 | Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells. | 2018 |
1 |
| 96 |
29608639 | Transition to Nonopioid Analgesia Does Not Impair Pain Control After Major Aesthetic Plastic Surgery. | 2018 Sep 14 |
1 |
| 97 |
29674687 | Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling. | 2018 Apr 19 |
3 |
| 98 |
29732985 | Treatment of Chronic Articular Pain in Adult People with Hemophilia. | 2018 |
1 |
| 99 |
29853736 | Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer. | 2018 May 28 |
1 |
| 100 |
29884091 | Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma. | 2018 |
1 |